Contracts › 75A50325F80013
75A50325F80013: Oseltamivir Phosphate 75MG Capsules (Ndc: 47781-470-13); 10 Ct. Blisters Packs and Oseltamivir Phosphate 30MG Capsules (Ndc: 47781-468-13); 10 Ct. Blisters Packs.
Awarded to Alvogen, Inc. by Office of Assistant Secretary for Preparedness and Response.
$227.7Mobligated
$227.7Mpotential value
29 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325F80013 |
|---|---|
| Vehicle | V797D70134 |
| Awardee | Alvogen, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NJ |
| Offers received | 3 |
| Period of performance | 30 June 2025 to 29 June 2027 |
| Potential end | 29 June 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record